Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)No trials found
News
Pretomanid Price Drops 25%, Boosting Access to Life-Saving TB Treatment Across Africa
The price of pretomanid, a critical component of drug-resistant tuberculosis treatment, has fallen to $169 per course, down from $364 in 2019, making it available for less than $1 per day.